immagine del discaff
 

Ph. D. Program in Pharmaceutical and Food Biotechnologies

Duration: 3 years
Awarding Body: University of Piemonte Orientale “Amedeo Avogadro”
School Site: DiSCAFF, Via Bovio 6, 28100 Novara
Coordinator of the Program: Prof. Menico Rizzi

Description

This three years PhD program exploits a combination of analytical, chemical, molecular and cellular biology approaches to identify and characterize novel molecular targets for the discovery of innovative pharmacological therapeutics, as well as for the development of innovative biomaterials and new tools in the areas of food authenticity and safety.

Selection Procedure

Fellowships are awarded from different bodies including the "Amedeo Avogadro" University of Piemonte Orientale, Private Foundations, Biotechnology Companies, Pharmaceutical and Food Industries, as well as basing upon specific grants delivered to the Scientists participating in the Ph.D. program. The selection procedure is carried out on an equal opportunity base, according to the Italian legislation concerning the PhD programs. A specific call for application is launched every year in August-September and the selected candidates start the research activity in November under the supervision of one of the participating Scientists. Details and deadline for call for application can be found at http://wwww.unipmn.it/.

Research Topics

  • Analytical tools for food authenticity and safety: Dr. J.D. Coisson (coisson@pharm.unipmn.it)
  • Biotechnological applications for food authenticity and safety: Dr. M. Arlorio (arlorio@pharm.unipmn.it)
  • Biotechnological development of innovative bioplastics: Dr. C. Bastioli CEO Novamont Spa – Novara (bastioli@novamont.com)
  • Molecular and cellular biology of signal transduction: Dr. L. Moro (moro@pharm.unipmn.it)
  • Molecular biology of oncogenes and cancerogenesis: Dr. G. Gaudino (gaudino@pharm.unipmn.it)
  • Cellular biology studies of biocompatible materials: Dr. M. Bosetti (bosetti@pharm.unipmn.it)
  • Molecular biology studies on calcium signalling: Dr. A.A. Genazzani (genazzani@pharm.unipmn.it)
  • Drugs and bioactive substances analysis: Dr. E. Del Grosso (delgrosso@pharm.unipmn.it)
  • Mathematical models for biotechnological applications: Dr. M. Rinaldi (rinaldi@pharm.unipmn.it)
  • Neuropharmacology and neuroplasticity: Dr. M. Grilli (grilli@pharm.unipmn.it)
  • Molecular studies on programmed cell death in cancer: Dr. F. Condorelli (condorelli@pharm.unipmn.it)
  • Pharmaceutical Microbiology: Dr. M.G. Martinotti (martinotti@pharm.unipmn.it)
  • Cell physiology of nervous system development: Dr. C. Distasi (distasi@pharm.unipmn.it)
  • Structural enzymology: Dr. M. Rizzi (rizzi@pharm.unipmn.it)
  • Synthesis of new chemical agents for diagnostic and therapeutic applications: Dr. G.B. Giovenzana ( giovenzana@pharm.unipmn.it)
  • Cancer immunotherapy-biochemistry: Dr. F. Martin Research Director Dompè Spa - L'Aquila (franck.martin@dompe.it)
  • Vaccines design: Dr. M.G. Pizza Research Director Novartis Vaccines - Siena (mariagrazia_pizza@chiron.com)
  • Pharmaceutical Economics, policy and management: Dr. Claudio Jommi (claudio.jommi@pharm.unipmn.it)
  • Ubiquitination as signalling device. Role of ubiquitin binding domains in the regulation of protein function: Dr. Lorenza Penengo (lorenza.penengo@pharm.unipmn.it)
  • Microbial Biodiversity: Dr. L. Fracchia (fracchia@pharm.unipmn.it)
  • Identification of inflammatory molecules and mechanisms promoting the protumoral phenotype of tumour-associated myelomonocytic cells and the elucidation of the role of selected targets in disease progression. Dr. A. Sica (antonio.sica@pharm.unipmn.it)
Please inquire with the respective Scientist for information on the specific research topic. For general information please contact Dr. Menico Rizzi (Tel. +39 0321 375 812; email rizzi@pharm.unipmn.it)